SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-20-050084
Filing Date
2020-02-26
Accepted
2020-02-26 16:13:15
Documents
97
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d843865d10k.htm   iXBRL 10-K 3717022
2 EX-4.2 d843865dex42.htm EX-4.2 20508
3 EX-10.20 d843865dex1020.htm EX-10.20 429861
4 EX-10.21 d843865dex1021.htm EX-10.21 772250
5 EX-21.1 d843865dex211.htm EX-21.1 721
6 EX-23.1 d843865dex231.htm EX-23.1 3223
7 EX-31.1 d843865dex311.htm EX-31.1 11625
8 EX-31.2 d843865dex312.htm EX-31.2 11584
9 EX-32.1 d843865dex321.htm EX-32.1 4438
10 EX-32.2 d843865dex322.htm EX-32.2 4414
16 GRAPHIC g843865g64e66.jpg GRAPHIC 130281
17 GRAPHIC g843865g70a53.jpg GRAPHIC 88304
18 GRAPHIC g843865g93s10.jpg GRAPHIC 71124
19 GRAPHIC g843865pmt70.jpg GRAPHIC 4131
20 GRAPHIC g843865pmt70b.jpg GRAPHIC 6398
  Complete submission text file 0001193125-20-050084.txt   14363947

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA gbt-20191231.xsd EX-101.SCH 58173
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20191231_cal.xml EX-101.CAL 57542
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20191231_def.xml EX-101.DEF 246831
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20191231_lab.xml EX-101.LAB 518119
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20191231_pre.xml EX-101.PRE 437649
37 EXTRACTED XBRL INSTANCE DOCUMENT d843865d10k_htm.xml XML 2445175
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37539 | Film No.: 20655810
SIC: 2834 Pharmaceutical Preparations